Buradasınız

Anasayfa » Content

İDİOPATİK NEFROTİK SENDROMLU ÇOCUKLARDA PNÖMOKOK AŞISININ ENFEKSİYON VE RÖLAPSLARA ETKİSİ

EFFECTS OF PNEUMOCOCCAL VACCINE ON INFECTIONS AND RELAPSES IN CHILDREN WITH NEPHROTIC SYNDROME

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 1997

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Eighteen steroid-responsive children with nephrotic syndrome were vaccinated with pneumococcal vaccine (PNEUMO-23) in order to investigate the effectiveness and necessity of this vaccine and they were followed up for three years. Twenty steroid-responsive children with nephrotic syndrome were also followed up for the same period without vaccination as a control group. Relaps rate in the study group after vaccination was 1 / 19.1 patient months, while it was 1/16 patient months in the control group, and a significant difference was found between them (p < 0.05). Infection rate oj relapses was also significantly lower in the study group (62.5 %) than the control group (55.5 %) (p < 0.01). Thirteen patients whose follow-up period was more than one year before vaccination showed a significant decrease in relaps rate after vaccination which was found to be 1 / 13.3 ± 1 / 57.14 patient months (p < 0.01). Infection rates of relapses in the study group also decreased after vaccination (p < 0.001). This study showed that pneumococcal vaccination decreased the frequency of relapses and infection rate in children with nephrotic syndrome and it is concluded that routine vaccination of these patients would be of benefit.
Bookmark/Search this post with
Abstract (Original Language): 
tdiopatik nefrotik sendromlu çocuklarda pnömokok aşısının etkinliğini ve bu hastaların takip ve tedavisinde rutin olarak kullanılmasının gerekliliğini araştırmak üzere 18 steroide cevaplı nefrotik sendromlu çocuğa saflaştırılmış pnömokok aşısı (PNEUMO-23) yapıldı ve aşı sonrası 3 yıl izlendi. Kontrol grubu olarak alınan 20 steroide cevaplı nefrotik sendromlu çocuk ise aynı süre içinde aşı yapılmadan izlendi. Çalışma grubunda aşı sonrası rölaps sıklığı 1 / 19.1 hasta ayı, kontrol grubunda ise 1/16 hasta ayı olarak bulundu ve arada istatistiksel olarak anlamlı fark saptandı (p < 0.05). Çalışma grubunda rölapslardaki enfeksiyon oranı % 62.5, kontrol grubunda % 55.5 olarak bulundu ve arada anlamlı fark tesbit edildi (p < 0.01). Aşı öncesi izlem süresi bir yılın üzerinde olan 13 hastanın rölaps sıklığında aşı sonrası 1 /13.3 ±1 / 57.14 hasta ayı kadar düşüş olduğu saptandı ve istatistiksel olarak anlamlı bulundu (p < 0.01). Çalışma grubunda aşı öncesi ve sonrası rölapslardaki enfeksiyon oranında ise anlamlı düşme görüldü (p < 0.001). Sonuç olarak pnömokok aşısının nefrotik sendromlu çocuklarda rölaps sıklığını ve enfeksiyon oranını azalttığı gösterilerek bu çocukların rutin olarak aşılanmasının yararlı olabileceği sonucuna varıldı.
FULL TEXT (PDF): 
PDF icon pdf_tndt_173.pdf
  • 1-2
80-83
  • Turkish

REFERENCES

References: 

1. Kelsch RC, Sedman AB. Nephrotic syndrome. Pediatrics in Review 1993; 1:30-38.
2. Bernard DB. Extrarenal complications of the nephrotic syndrome. Kidney Int 1988; 33:1184-1202.
3. Cameron JS. The nephrotic syndrome and its complications. Am J Kid Dis 1987; 10:157-171.
4.
Öne
r A, Demircin G, Bülbül M. Çocukluk çağı idiopatik nefrotik sendromlannda rölapslara etki eden faktörler ve prognoz üzerine etkisi. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 1995; 2:80-85.
5. Melvin T, Bennett W. Management of nephrotic syndrome in childhood. Drugs 1991; 42:30-51.
6. Mallick NP. Epidemiology and natural course of idiopathic nephrotic syndrome. Clin Nephrol 1991; 35
Suppll:S3-S7.
7. Bülbül M, Öner A. Nefrotik sendrom. Yeni Tıp Dergisi 1995;12:175-182.
8. Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ. Nephrotic syndrome: From toddlers to
twenties. Lancet 1989; 4: 255-259.
9. Trompeter RS. Immunosuppressive therapy in the nephrotic syndrome in children. Pediatr Nephrol 1989; 3:194-200.
10. Brodehl J. Conventional therapy for idiopathic nephrotic syndrome in children. Clin Nephrol 1991; 35 Suppl 1:8¬15.
11. Krensky AM, Ingelfinger JR, Grupe WE. Peritonitis in childhood nephrotic syndrome. Am J Dis Child 1982; 136:732-736.
12. Primack WA, Rosel M, Thirumoorthi MC,
Fleischmann LE. Failure of pneumococcal vaccine to prevent streptococcus pneumoniae sepsis in nephrotic
children. Lancet 1979; 1:1192.
13. Tejani A, Fikrig S, Schiffman G, Gurumurthy K. Persistence of protective pneumococcal antibody following vaccination in patients with the nephrotic
syndrome. Am J Nephrol 1984; 4:32-37.
14. Moore DH, Schackelford PG, Robson AM, Rose GM.
Recurrent pneumococcal sepsis and defective opsonization after pneumococcal capsular polysaccaride vaccine in a child with nephrotic syndrome. J Pediatr 1980;96:882-885.
15. Spika JS, Halsey NA, Fish A.T, Lum GM, Lauer BA,
Schiffman G, Giebink GS. Serum antibody response to pneumococcal vaccine in children with nephrotic
syndrome. Pediatrics 1982; 69:219-223.
16. Fikrig SK, Schiffmann G, Phillipp JC, Moel DI.
Antibody response to capsular polysaccaride vaccine of streptococcus pneumoniae in patients with nephrotic
syndrome. J Infect Dis 1978; 137:818-821.
17. Schnaper HW. Immunization practices in childhood nephrotic syndrome:a survey of North American pediatric nephrologists. Pediatr Nephrol 1994; 8:4-6.
18. Steele RW. Current status of vaccines and immunoglo-bulins for children with renal disease. Pediatr Nephrol 1994; 8:7-10.
19. Garin EH, Barett DJ. Pneumococcal polysaccharide immunization in patients with active nephrotic
syndrome. Nephron 1988; 50:383-388.
20. Mendoza SA, Tune BM. Management of the difficult nephrotic patient. Pediatr Clin North Am 1995; 42:1459-1468.

Thank you for copying data from http://www.arastirmax.com